Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
SHIVERING; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shivering in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included influenza vaccine for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix and influenza vaccine. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shivering (Verbatim: SHIVERING). The action taken with influenza vaccine was unknown. The outcome of the shivering was resolved. It was unknown if the reporter considered the shivering to be related to Shingrix. It was unknown if the company considered the shivering to be related to Shingrix. Additional Information: GSK receipt date: 24-MAY-2025 The reporter reported that he/she made the mistake of getting my first Shingrix with my flu shot. Several days under several blankets, shivering.